| Year |
Citation |
Score |
| 2020 |
Cruz L, György B, Cheah PS, Kleinstiver BP, Eimer WA, Garcia SP, Sharma N, Ozelius LJ, Bragg DC, Joung JK, Norberto de Souza O, Macedo Timmers LFS, Breakefield XO. Mutant Allele-Specific CRISPR Disruption in DYT1 Dystonia Fibroblasts Restores Cell Function. Molecular Therapy. Nucleic Acids. 21: 1-12. PMID 32502938 DOI: 10.1016/J.Omtn.2020.05.009 |
0.315 |
|
| 2020 |
Stephen CD, Go CL, Acuna P, Sharma N. Phasic Knee Bending Dystonic and Parkinsonian Gait: A Characteristic Finding in X-Linked Dystonia Parkinsonism. Movement Disorders Clinical Practice. 7: 448-452. PMID 32373662 DOI: 10.1002/Mdc3.12929 |
0.305 |
|
| 2020 |
Lungu C, Ozelius L, Standaert D, Hallett M, Sieber BA, Swanson-Fisher C, Berman BD, Calakos N, Moore JC, Perlmutter JS, Pirio Richardson SE, Saunders-Pullman R, Scheinfeldt L, Sharma N, Sillitoe R, et al. Defining research priorities in dystonia. Neurology. PMID 32098856 DOI: 10.1212/Wnl.0000000000009140 |
0.475 |
|
| 2019 |
Bragg DC, Sharma N, Ozelius LJ. X-Linked Dystonia-Parkinsonism: recent advances. Current Opinion in Neurology. PMID 31116117 DOI: 10.1097/Wco.0000000000000708 |
0.311 |
|
| 2016 |
de Gusmao CM, Dy M, Sharma N. Beyond Dystonia-Parkinsonism: Chorea and Ataxia with ATP1A3 Mutations. Movement Disorders Clinical Practice. 3: 402-404. PMID 30363590 DOI: 10.1002/Mdc3.12317 |
0.327 |
|
| 2016 |
Vaine CA, Shin D, Liu C, Hendriks W, Dhakal J, Shin K, Sharma N, Bragg C. X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B. Neurobiology of Disease. PMID 28017799 DOI: 10.1016/J.Nbd.2016.12.016 |
0.318 |
|
| 2016 |
Rittiner JE, Caffall ZF, Hernández-Martinez R, Sanderson SM, Pearson JL, Tsukayama KK, Liu AY, Xiao C, Tracy S, Shipman MK, Hickey P, Johnson J, Scott B, Stacy M, Saunders-Pullman R, ... ... Sharma N, et al. Functional Genomic Analyses of Mendelian and Sporadic Disease Identify Impaired eIF2α Signaling as a Generalizable Mechanism for Dystonia. Neuron. PMID 27939583 DOI: 10.1016/J.Neuron.2016.11.012 |
0.33 |
|
| 2016 |
de Gusmão CM, Fuchs T, Moses A, Multhaupt-Buell T, Song PC, Ozelius LJ, Franco RA, Sharma N. Dystonia-Causing Mutations as a Contribution to the Etiology of Spasmodic Dysphonia. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. PMID 27188707 DOI: 10.1177/0194599816648293 |
0.311 |
|
| 2016 |
Waugh JL, Kuster JK, Levenstein JM, Makris N, Multhaupt-Buell TJ, Sudarsky LR, Breiter HC, Sharma N, Blood AJ. Thalamic Volume Is Reduced in Cervical and Laryngeal Dystonias. Plos One. 11: e0155302. PMID 27171035 DOI: 10.1371/Journal.Pone.0155302 |
0.316 |
|
| 2016 |
Dy ME, Chang FC, De Jesus S, Anselm I, Mahant N, Zeilman P, Rodan LH, Foote KD, Tan WH, Eskandar E, Sharma N, Okun MS, Fung VS, Waugh JL. Treatment of ADCY5-Associated Dystonia, Chorea, and Hyperkinetic Disorders With Deep Brain Stimulation: A Multicenter Case Series. Journal of Child Neurology. PMID 27052971 DOI: 10.1177/0883073816635749 |
0.347 |
|
| 2016 |
Ito N, Hendriks WT, Dhakal J, Vaine CA, Liu C, Shin D, Shin K, Wakabayashi-Ito N, Dy M, Multhaupt-Buell T, Sharma N, Breakefield XO, Bragg DC. Decreased N-TAF1 expression in X-Linked Dystonia-Parkinsonism patient-specific neural stem cells. Disease Models & Mechanisms. PMID 26769797 DOI: 10.1242/Dmm.022590 |
0.311 |
|
| 2015 |
Zhang L, McCarthy DM, Sharma N, Bhide PG. Dopamine receptor and Gα(olf) expression in DYT1 dystonia mouse models during postnatal development. Plos One. 10: e0123104. PMID 25860259 DOI: 10.1371/Journal.Pone.0123104 |
0.34 |
|
| 2013 |
Waugh JL, Sharma N. Clinical neurogenetics: dystonia from phenotype to genotype. Neurologic Clinics. 31: 969-86. PMID 24176419 DOI: 10.1016/J.Ncl.2013.04.002 |
0.313 |
|
| 2013 |
Armata IA, Balaj L, Kuster JK, Zhang X, Tsai S, Armatas AA, Multhaupt-Buell TJ, Soberman R, Breakefield XO, Ichinose H, Sharma N. Dopa-responsive dystonia: functional analysis of single nucleotide substitutions within the 5' untranslated GCH1 region. Plos One. 8: e76975. PMID 24124602 DOI: 10.1371/Journal.Pone.0076975 |
0.306 |
|
| 2013 |
Fuchs T, Saunders-Pullman R, Masuho I, Luciano MS, Raymond D, Factor S, Lang AE, Liang TW, Trosch RM, White S, Ainehsazan E, Hervé D, Sharma N, Ehrlich ME, Martemyanov KA, et al. Mutations in GNAL cause primary torsion dystonia Nature Genetics. 45: 88-92. PMID 23222958 DOI: 10.1038/Ng.2496 |
0.319 |
|
| 2013 |
Vaughn LS, Bragg DC, Sharma N, Camargos S, Cardoso F, Patel RC. 268 Cytokine. 63: 306-307. DOI: 10.1016/J.Cyto.2013.06.271 |
0.303 |
|
| 2012 |
McCarthy DM, Gioioso V, Zhang X, Sharma N, Bhide PG. Neurogenesis and neuronal migration in the forebrain of the TorsinA knockout mouse embryo. Developmental Neuroscience. 34: 366-78. PMID 23018676 DOI: 10.1159/000342260 |
0.301 |
|
| 2012 |
Blood AJ, Kuster JK, Woodman SC, Kirlic N, Makhlouf ML, Multhaupt-Buell TJ, Makris N, Parent M, Sudarsky LR, Sjalander G, Breiter H, Breiter HC, Sharma N. Evidence for altered basal ganglia-brainstem connections in cervical dystonia. Plos One. 7: e31654. PMID 22384048 DOI: 10.1371/Journal.Pone.0031654 |
0.318 |
|
| 2011 |
Zhao Y, Sharma N, LeDoux MS. The DYT1 carrier state increases energy demand in the olivocerebellar network Neuroscience. 177: 183-194. PMID 21241782 DOI: 10.1016/J.Neuroscience.2011.01.015 |
0.321 |
|
| 2011 |
Bragg DC, Armata IA, Nery FC, Breakefield XO, Sharma N. Molecular pathways in dystonia. Neurobiology of Disease. 42: 136-47. PMID 21134457 DOI: 10.1016/J.Nbd.2010.11.015 |
0.334 |
|
| 2010 |
Hewett J, Johanson P, Sharma N, Standaert D, Balcioglu A. Function of dopamine transporter is compromised in DYT1 transgenic animal model in vivo. Journal of Neurochemistry. 113: 228-35. PMID 20132487 DOI: 10.1111/J.1471-4159.2010.06590.X |
0.534 |
|
| 2009 |
Martella G, Tassone A, Sciamanna G, Platania P, Cuomo D, Viscomi MT, Bonsi P, Cacci E, Biagioni S, Usiello A, Bernardi G, Sharma N, Standaert DG, Pisani A. Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. Brain : a Journal of Neurology. 132: 2336-49. PMID 19641103 DOI: 10.1093/Brain/Awp194 |
0.544 |
|
| 2009 |
Sciamanna G, Bonsi P, Tassone A, Cuomo D, Tscherter A, Viscomi MT, Martella G, Sharma N, Bernardi G, Standaert DG, Pisani A. Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia. Neurobiology of Disease. 34: 133-45. PMID 19187797 DOI: 10.1016/J.Nbd.2009.01.001 |
0.514 |
|
| 2007 |
Balcioglu A, Kim MO, Sharma N, Cha JH, Breakefield XO, Standaert DG. Dopamine release is impaired in a mouse model of DYT1 dystonia. Journal of Neurochemistry. 102: 783-8. PMID 17550429 DOI: 10.1111/J.1471-4159.2007.04590.X |
0.529 |
|
| 2006 |
Blood AJ, Tuch DS, Makris N, Makhlouf ML, Sudarsky LR, Sharma N. White matter abnormalities in dystonia normalize after botulinum toxin treatment. Neuroreport. 17: 1251-5. PMID 16951564 DOI: 10.1097/01.Wnr.0000230500.03330.01 |
0.303 |
|
| 2006 |
Pisani A, Martella G, Tscherter A, Bonsi P, Sharma N, Bernardi G, Standaert DG. Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia. Neurobiology of Disease. 24: 318-25. PMID 16934985 DOI: 10.1016/J.Nbd.2006.07.006 |
0.526 |
|
| 2005 |
Sharma N, Baxter MG, Petravicz J, Bragg DC, Schienda A, Standaert DG, Breakefield XO. Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 5351-5. PMID 15930383 DOI: 10.1523/Jneurosci.0855-05.2005 |
0.551 |
|
| 2005 |
Sharma N, Cristopher Bragg D, Petravicz J, Standaert DG, Breakefield XO. DYT1 transgenic mouse Movement Disorders. 287-292. DOI: 10.1016/B978-012088382-0/50024-4 |
0.444 |
|
| 2002 |
Sharma N, Standaert DG. Inherited movement disorders. Neurologic Clinics. 20: 759-78, vii. PMID 12432829 DOI: 10.1016/S0733-8619(01)00014-7 |
0.541 |
|
| Show low-probability matches. |